Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
Get Alerts CTNM Hot Sheet
Join SI Premium – FREE
Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q2 EPS of ($0.40), $0.04 better than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Oceanfirst Financial (OCFC) Reports In-Line Q2 EPS
- Pathfinder Bancorp (PBHC) Tops Q2 EPS by 42c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share